logo

For the Inventor, By the Inventor

Marburg, Germany

Novartis Vaccines & Diagnostics, Gmbh


USPTO Granted Patents = 245



Trademarks = 10

Forward Citations = 2,176

Loading Chart...
Loading Chart...

387 inventors (with patents filed for the assignee):

goldMedal Susan Barnett (21 out of 29 patents)

silverMedal Michael Houghton (20 out of 109 patents)

bronzeMedal Derek T O'Hagan (19 out of 73 patents)

4.  Savithri Ramurthy (15 out of 37 patents)

5.  Paul A Renhowe (14 out of 59 patents)

6.  Weibo Wang (13 out of 38 patents)

7.  Doris Guenzi Coit (13 out of 28 patents)

8.  Angelica Medina-Selby (13 out of 30 patents)

9.  Jan Zur Megede (13 out of 18 patents)

10.  Christoph Reinhard (13 out of 23 patents)

11.  David Y Chien (12 out of 32 patents)

12.  Manmohan Singh (11 out of 54 patents)

13.  Guido Grandi (11 out of 110 patents)

14.  Sharadha Subramanian (11 out of 26 patents)

15.  John M Polo (11 out of 27 patents)


Core Competencies:
Monoclonal Antibodies
Alphavirus Vectors
HIV Vaccine Formulations
Immunogenic Compositions
Nucleic Acid Vectors
Chimeric Proteins
Microemulsions
Cancer Gene Therapy
Antiviral Immune Response
Serogroup C Meningococcus
FGF Proteins
RNA Interference

245 patents:

1. 11034759 - Humanized M-CSF specific monoclonal antibodies, kits, and uses thereof (2021-06-15),
2. 9926371 - M-CSF specific monoclonal antibody and uses thereof (2018-03-27),
3. 9730997 - Alphavirus vectors for respiratory pathogen vaccines (2017-08-15),
4. 9598469 - HIV-1 south african subtype C env proteins (2017-03-21),
5. 9522186 - M-CSF specific monoclonal antibody and uses therof (2016-12-20),
6. 9428739 - Norovirus and Sapovirus antigens (2016-08-30),
7. 9255126 - Chimeric alphavirus replicon particles (2016-02-09),
8. 9149507 - Method of treating coronary artery disease by administering FGF-9 (2015-10-06),
9. 9079956 - M-CSF specific monoclonal antibody and uses thereof (2015-07-14),
10. 9024001 - Alphavirus replicon packaging constructs (2015-05-05),
11. RE45137 - Adjuvanted meningococcus compositions (2014-09-15),
12. 8796211 - Method of treating coronary artery disease FGF-2 (2014-08-05),
13. 8778358 - [object Object] (2014-07-15),
14. 8772255 - Cell transfecting formulations of small interfering RNA related compositions and methods of making and use (2014-07-08),
15. 8771747 - Microemulsions with adsorbed macromolecules and microparticles (2014-07-08),
Novartis Vaccines & Diagnostics, GmbH is a leading global pharmaceutical company specializing in the development and manufacturing of vaccines and diagnostic tools. With a strong commitment to improving global health, Novartis Vaccines & Diagnostics strives to discover innovative solutions to prevent and combat infectious diseases. Through extensive research and development, the company aims to provide safe and effective vaccines that meet the highest quality standards. Visit their website for more information on their products and initiatives.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

245 Patents

#2 in Marburg

#268 in Germany

#3,423 in the World

...
Marburg, Germany

Novartis Vaccines & Diagnostics, Gmbh

Forward Citations = 2,176

387 inventors:

goldMedal Susan Barnett (21 out of 29 patents)

silverMedal Michael Houghton (20 out of 109 patents)

bronzeMedal Derek T O'Hagan (19 out of 73 patents)

4.  Savithri Ramurthy (15 out of 37 patents)

5.  Paul A Renhowe (14 out of 59 patents)

Please report any incorrect information to support@idiyas.com
Loading…